These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1689534)

  • 21. Overview: moricizine--can it meet the challenge?
    Morganroth J; Bigger JT
    Am J Cardiol; 1990 Feb; 65(8):1D-2D; discussion 68D-71D. PubMed ID: 2407086
    [No Abstract]   [Full Text] [Related]  

  • 22. Natural history of potentially lethal ventricular arrhythmias in patients treated with long-term antiarrhythmic drug therapy.
    Kennedy HL; Sprague MK; Homan SM; Seiler SM; Wiens RD; Janosik DL; Redd RM; Buckingham TA
    Am J Cardiol; 1989 Dec; 64(19):1289-97. PubMed ID: 2686388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Initial results of clinical research on a tabletted form of ethacizin (the diethylamino analog of ethmozine) in ventricular arrhythmias].
    Rozenshtraukh LV; Shugushev KhKh; Smetnev AS; Mukharliamov NM; Ponomarenko EL
    Kardiologiia; 1985 Mar; 25(3):43-50. PubMed ID: 2582177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
    Smetnev AS; Ponomarenko EL; Koltunova MI; Shugushev KhKh
    Kardiologiia; 1987 May; 27(5):24-6. PubMed ID: 2443743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethacizin: a new efficacious Soviet antiarrhythmic drug of the phenothiazine group.
    Rosenshtraukh LV; Shugushev KK; Smetnev AS
    Am Heart J; 1986 Nov; 112(5):932-9. PubMed ID: 3535466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placement of moricizine in the selection of antiarrhythmic drug therapy.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):65D-67D; discussion 68D-71D. PubMed ID: 2407093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of moricizine in patients with congestive heart failure: a summary of the experience in the United States.
    Pratt CM; Podrid P; Greatrix B; Borland RM; Mahler S
    Am Heart J; 1990 Jan; 119(1):1-7. PubMed ID: 1688682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
    Anderson JL
    Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of prolonged ethmozine treatment in patients with ventricular arrhythmias].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1983 Nov; 23(11):51-5. PubMed ID: 6197557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
    Podrid PJ; Beau SL
    Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of ethacizin in ventricular arrhythmias refractory to prior anti-arrhythmia drug therapy].
    Shugushev KhKh
    Kardiologiia; 1986 Jun; 26(6):43-7. PubMed ID: 2429007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).
    Morganroth J; Pratt CM
    Am J Cardiol; 1989 Jan; 63(3):172-6. PubMed ID: 2642632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy.
    Pratt CM; Delclos G; Wierman AM; Mahler SA; Seals AA; Leon CA; Young JB; Quinones MA; Roberts R
    N Engl J Med; 1985 Dec; 313(23):1444-9. PubMed ID: 3903506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.
    Am J Cardiol; 1988 Apr; 61(10):704-13. PubMed ID: 2451414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative effectiveness of neogilurytmal, novocainamide, etmozin, disopyramide and ethacizine in ventricular arrhythmias].
    Shpektor AV; Gorshkov VA; Mamaev VI
    Klin Med (Mosk); 1987 Jan; 65(1):49-52. PubMed ID: 2435956
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
    Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
    Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.